Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
The four dengue virus serotypes (DENV1 to 4) cause dengue, a major public health problem worldwide. Individuals exposed to primary DENV infections develop serotype-specific neutralizing antibodies, including strongly neutralizing antibodies targeting quaternary epitopes. To date, no studies have mea...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2017-09-01
|
Series: | mBio |
Online Access: | http://mbio.asm.org/cgi/content/full/8/5/e01205-17 |
id |
doaj-23d65729302e41dd9b1d63d8a6919730 |
---|---|
record_format |
Article |
spelling |
doaj-23d65729302e41dd9b1d63d8a69197302021-07-02T09:05:25ZengAmerican Society for MicrobiologymBio2150-75112017-09-0185e01205-1710.1128/mBio.01205-17Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific EpitopesDaniela V. AndradeLeah C. KatzelnickDoug G. WidmanAngel BalmasedaAravinda M. de SilvaRalph S. BaricEva HarrisDiane E. GriffinThe four dengue virus serotypes (DENV1 to 4) cause dengue, a major public health problem worldwide. Individuals exposed to primary DENV infections develop serotype-specific neutralizing antibodies, including strongly neutralizing antibodies targeting quaternary epitopes. To date, no studies have measured the levels and kinetics of serum antibodies directed to such epitopes among populations in regions where dengue is endemic. Here, we use a recombinant DENV4 (rDENV4/3-M14) displaying a major DENV3 type-specific quaternary epitope recognized by human monoclonal antibody 5J7 to measure the proportion, magnitude, and kinetics of DENV3 type-specific neutralizing antibody responses targeting this epitope. Primary DENV3 sera from 30 individuals in a dengue hospital-based study in Nicaragua were studied 3, 6, 12, and 18 months post-infection, alongside samples collected annually 1 to 4 years post-primary DENV3 infection from 10 individuals in a cohort study in Nicaragua. We found substantial individual variation in the proportion of DENV3 type-specific neutralizing antibody titers attributed to the 5J7 epitope (range, 0 to 100%), with the mean significantly increasing from 22.6% to 41.4% from 3 to 18 months. We extended the transplanted DENV3 5J7 epitope on the virion (rDENV4/3-M16), resulting in increased recognition in several individuals, helping define the footprint of the epitope. However, 37% and 13% of the subjects still showed little to no recognition of the 5J7 epitope at 3 and 18 months, respectively, indicating that one or more additional DENV3 type-specific epitopes exist. Overall, this study demonstrates how DENV-immune plasma from populations from areas of endemicity, when coupled with structurally guided recombinant viruses, can help characterize the epitope-specific neutralizing antibody response in natural DENV infections, with direct implications for design and evaluation of dengue vaccines.http://mbio.asm.org/cgi/content/full/8/5/e01205-17 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniela V. Andrade Leah C. Katzelnick Doug G. Widman Angel Balmaseda Aravinda M. de Silva Ralph S. Baric Eva Harris Diane E. Griffin |
spellingShingle |
Daniela V. Andrade Leah C. Katzelnick Doug G. Widman Angel Balmaseda Aravinda M. de Silva Ralph S. Baric Eva Harris Diane E. Griffin Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes mBio |
author_facet |
Daniela V. Andrade Leah C. Katzelnick Doug G. Widman Angel Balmaseda Aravinda M. de Silva Ralph S. Baric Eva Harris Diane E. Griffin |
author_sort |
Daniela V. Andrade |
title |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes |
title_short |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes |
title_full |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes |
title_fullStr |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes |
title_full_unstemmed |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes |
title_sort |
analysis of individuals from a dengue-endemic region helps define the footprint and repertoire of antibodies targeting dengue virus 3 type-specific epitopes |
publisher |
American Society for Microbiology |
series |
mBio |
issn |
2150-7511 |
publishDate |
2017-09-01 |
description |
The four dengue virus serotypes (DENV1 to 4) cause dengue, a major public health problem worldwide. Individuals exposed to primary DENV infections develop serotype-specific neutralizing antibodies, including strongly neutralizing antibodies targeting quaternary epitopes. To date, no studies have measured the levels and kinetics of serum antibodies directed to such epitopes among populations in regions where dengue is endemic. Here, we use a recombinant DENV4 (rDENV4/3-M14) displaying a major DENV3 type-specific quaternary epitope recognized by human monoclonal antibody 5J7 to measure the proportion, magnitude, and kinetics of DENV3 type-specific neutralizing antibody responses targeting this epitope. Primary DENV3 sera from 30 individuals in a dengue hospital-based study in Nicaragua were studied 3, 6, 12, and 18 months post-infection, alongside samples collected annually 1 to 4 years post-primary DENV3 infection from 10 individuals in a cohort study in Nicaragua. We found substantial individual variation in the proportion of DENV3 type-specific neutralizing antibody titers attributed to the 5J7 epitope (range, 0 to 100%), with the mean significantly increasing from 22.6% to 41.4% from 3 to 18 months. We extended the transplanted DENV3 5J7 epitope on the virion (rDENV4/3-M16), resulting in increased recognition in several individuals, helping define the footprint of the epitope. However, 37% and 13% of the subjects still showed little to no recognition of the 5J7 epitope at 3 and 18 months, respectively, indicating that one or more additional DENV3 type-specific epitopes exist. Overall, this study demonstrates how DENV-immune plasma from populations from areas of endemicity, when coupled with structurally guided recombinant viruses, can help characterize the epitope-specific neutralizing antibody response in natural DENV infections, with direct implications for design and evaluation of dengue vaccines. |
url |
http://mbio.asm.org/cgi/content/full/8/5/e01205-17 |
work_keys_str_mv |
AT danielavandrade analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT leahckatzelnick analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT douggwidman analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT angelbalmaseda analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT aravindamdesilva analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT ralphsbaric analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT evaharris analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes AT dianeegriffin analysisofindividualsfromadengueendemicregionhelpsdefinethefootprintandrepertoireofantibodiestargetingdenguevirus3typespecificepitopes |
_version_ |
1721333484283232256 |